Supplementary Material

Published: 2 December 2021| Version 1 | DOI: 10.17632/mw73mzm8mm.1
Contributor:
Pasquale Bufano

Description

Supplementary Table 1: PRISMA Check-List (Moher et al., 2009; Page et al.,2021) Supplementary Table 2: Appraisal tool for Cross-Sectional Studies (AXIS; Downes et al., 2016) Supplementary Table 3: PRISMA Abstract Check-List (Page et al.,2021) Supplementary references Downes, M. J., Brennan, M. L., Williams, H. C., & Dean, R. S. (2016). Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS). BMJ Open, 6(12), e011458. https://doi.org/10.1136/bmjopen-2016-011458 Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), e1000097. https://doi.org/10.1371/journal.pmed.1000097 Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., ... & Moher, D. (2021). The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Bmj, 372 :n71. doi:10.1136/bmj.n71

Files

Categories

Addiction

Licence